Joseph Vittiglio Insider Trading $AVM AMAG PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Joseph Vittiglio.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Joseph Vittiglio. Joseph Vittiglio is CBO, General Counsel in AMAG PHARMACEUTICALS, INC. ($AVM) and Chief Business Officer, GC in AMAG PHARMACEUTICALS, INC. ($AVM) and EVP, General Counsel in AMAG PHARMACEUTICALS INC. ($AVM) and SVP, General Counsel in AMAG PHARMACEUTICALS INC. ($AVM) and SVP & General Counsel in AVEO PHARMACEUTICALS INC ($AVEO) and General Counsel and Secretary in Finch Therapeutics Group, Inc. ($FNCH).
Joseph Vittiglio in AMAG PHARMACEUTICALS, INC.
Trading Symbol: AVMIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Joseph Vittiglio: Chief Business Officer, GC, CBO, General Counsel, EVP, General Counsel, SVP, General Counsel
Holdings: 0 shares
Latest Transaction: Nov 17 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Joseph Vittiglio in AMAG PHARMACEUTICALS, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AVM, AVEO, FNCH
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | Chief Business Offi ... | Option Exercise | D | 0.00 | 35,000 | 0 | 0 | |
Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | Chief Business Offi ... | Option Exercise | D | 0.00 | 25,000 | 0 | 0 | |
Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | Chief Business Offi ... | Option Exercise | D | 0.00 | 20,000 | 0 | 0 | |
Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | Chief Business Offi ... | Option Exercise | D | 0.00 | 20,000 | 0 | 0 | |
Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | Chief Business Offi ... | Option Exercise | D | 0.00 | 20,000 | 0 | 0 | |
Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | Chief Business Offi ... | Option Exercise | D | 0.00 | 30,000 | 0 | 0 | |
Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | Chief Business Offi ... | Sell | D | 0.00 | 92,244 | 0 | 0 | 92.2 K to 0 (-100.00 %) |
Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | Chief Business Offi ... | Option Exercise | D | 0.00 | 35,000 | 0 | 0 | |
Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | Chief Business Offi ... | Option Exercise | D | 0.00 | 25,000 | 0 | 0 | |
Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | Chief Business Offi ... | Option Exercise | D | 0.00 | 20,000 | 0 | 0 | |
Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | Chief Business Offi ... | Option Exercise | D | 0.00 | 20,000 | 0 | 0 | |
Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | Chief Business Offi ... | Option Exercise | D | 0.00 | 20,000 | 0 | 0 | |
Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | Chief Business Offi ... | Option Exercise | D | 0.00 | 30,000 | 0 | 0 | |
Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | Chief Business Offi ... | Sell | D | 0.00 | 92,244 | 0 | 0 | 92.2 K to 0 (-100.00 %) |
Mar 12 2020 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | CBO, General Counse ... | Option Exercise | A | 7.27 | 35,000 | 254,450 | 35,000 | |
Mar 12 2020 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | CBO, General Counse ... | Grant | A | 0.00 | 25,000 | 0 | 92,244 | 67.2 K to 92.2 K (+37.18 %) |
Mar 04 2020 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | CBO, General Counse ... | Payment of Exercise | F | 7.75 | 1,138 | 8,820 | 67,244 | 68.4 K to 67.2 K (-1.66 %) |
Feb 25 2020 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | CBO, General Counse ... | Payment of Exercise | F | 8.84 | 2,206 | 19,501 | 75,882 | 78.1 K to 75.9 K (-2.83 %) |
Feb 25 2020 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | CBO, General Counse ... | Payment of Exercise | F | 9.50 | 867 | 8,237 | 78,088 | 79 K to 78.1 K (-1.10 %) |
Mar 11 2019 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | EVP, General Counse ... | Sell | S | 14.01 | 1,425 | 19,964 | 78,955 | 80.4 K to 79 K (-1.77 %) |
Feb 27 2019 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | EVP, General Counse ... | Option Exercise | A | 15.51 | 25,000 | 387,750 | 25,000 | |
Feb 27 2019 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | EVP, General Counse ... | Grant | A | 0.00 | 12,000 | 0 | 82,512 | 70.5 K to 82.5 K (+17.02 %) |
Feb 27 2019 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | EVP, General Counse ... | Grant | A | 0.00 | 20,000 | 0 | 70,512 | 50.5 K to 70.5 K (+39.59 %) |
Feb 26 2019 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | EVP, General Counse ... | Payment of Exercise | F | 15.51 | 869 | 13,478 | 50,512 | 51.4 K to 50.5 K (-1.69 %) |
Aug 27 2018 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | EVP, General Counse ... | Payment of Exercise | F | 24.60 | 1,473 | 36,236 | 51,381 | 52.9 K to 51.4 K (-2.79 %) |
Mar 06 2018 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | EVP, General Counse ... | Option Exercise | A | 21.00 | 20,000 | 420,000 | 20,000 | |
Mar 06 2018 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | EVP, General Counse ... | Sell | S | 20.80 | 770 | 16,016 | 52,854 | 53.6 K to 52.9 K (-1.44 %) |
Mar 06 2018 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | EVP, General Counse ... | Payment of Exercise | F | 21.00 | 1,011 | 21,231 | 53,624 | 54.6 K to 53.6 K (-1.85 %) |
Mar 06 2018 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | EVP, General Counse ... | Grant | A | 0.00 | 10,000 | 0 | 54,635 | 44.6 K to 54.6 K (+22.40 %) |
Mar 06 2018 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | EVP, General Counse ... | Grant | A | 0.00 | 12,000 | 0 | 44,635 | 32.6 K to 44.6 K (+36.77 %) |
Mar 06 2018 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | EVP, General Counse ... | Payment of Exercise | F | 19.65 | 869 | 17,076 | 32,635 | 33.5 K to 32.6 K (-2.59 %) |
Aug 30 2017 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | SVP, General Counse ... | Sell | S | 16.75 | 1,250 | 20,938 | 33,504 | 34.8 K to 33.5 K (-3.60 %) |
Aug 28 2017 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | SVP, General Counse ... | Payment of Exercise | F | 17.50 | 1,633 | 28,578 | 34,754 | 36.4 K to 34.8 K (-4.49 %) |
May 10 2017 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | SVP, General Counse ... | Payment of Exercise | F | 18.55 | 980 | 18,179 | 36,387 | 37.4 K to 36.4 K (-2.62 %) |
Feb 27 2017 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | SVP, General Counse ... | Option Exercise | A | 23.75 | 20,000 | 475,000 | 20,000 | |
Feb 27 2017 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | SVP, General Counse ... | Grant | A | 0.00 | 7,500 | 0 | 37,367 | 29.9 K to 37.4 K (+25.11 %) |
Feb 27 2017 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | SVP, General Counse ... | Grant | A | 0.00 | 7,500 | 0 | 29,867 | 22.4 K to 29.9 K (+33.53 %) |
Aug 25 2016 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | SVP, General Counse ... | Payment of Exercise | F | 24.85 | 1,633 | 40,580 | 22,367 | 24 K to 22.4 K (-6.80 %) |
Mar 02 2016 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | SVP, General Counse ... | Option Exercise | A | 25.18 | 20,000 | 503,600 | 20,000 | |
Mar 02 2016 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | SVP, General Counse ... | Grant | A | 0.00 | 9,000 | 0 | 24,000 | 15 K to 24 K (+60.00 %) |
Aug 25 2015 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | SVP, General Counse ... | Option Exercise | A | 57.60 | 30,000 | 1,728,000 | 30,000 | |
Aug 25 2015 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | SVP, General Counse ... | Grant | A | 0.00 | 15,000 | 0 | 15,000 | 0 to 15 K |
Page: 1